Restore Hyper Wellness Review

Our assessment

Restore Hyper Wellness is a wellness chain with individually owned studios, and its GLP-1 page publishes both ends of a monthly range plus what moves you along it. That's more than a starting figure and less than a price. One figure covers both compounds, so nothing tells you what either costs on its own. Two further charges are named on the same page and neither is priced. And the studios set their own rates, so the published range isn't a commitment at the one nearest you.

A range with both ends published

The page asks how much it costs and answers with a floor and a ceiling, saying the figure varies with medication dosage and goals. The ceiling is more than three times the floor.

Publishing both ends beats the starting-at figure most of this comparison offers, because it shows you the top of the ladder and not only the bottom. It's still a range: it answers what a month might cost, not what yours will.

So don't budget on the floor. The page itself says the figure climbs with your dosage.

One figure, two molecules

The page states that a qualifying patient will be prescribed a compounded semaglutide or tirzepatide medication, and the range covers whichever one you get. Nothing says what either costs on its own.

Eighty-two of the four hundred and twenty sellers here publish a figure that names no molecule while still buying the medication.

The two drugs aren't interchangeable, and nowhere else in this comparison are they priced alike. If you've decided which one you want, this page won't tell you what it costs.

Two named charges with no numbers

The same paragraph that gives you the range says nurse practitioner calls and IV drips can be added for an additional fee. Both are named. Neither is priced.

That's a real gap on a page whose whole purpose is to answer a cost question, and a sitewide line saying services, therapies and prices may vary per location widens it. The published range is a national description of a locally set price.

Three hundred and twenty-six of the four hundred and twenty sellers here name no compounding pharmacy, and Restore is one of them. What gets prescribed is stated plainly as a compounded preparation. Who prepares it isn't.

The membership is for something else entirely

This chain runs a membership, and it's easy to assume it applies to the medication. It doesn't. The membership buys credits for the chain's core therapies and IV drips, and the GLP-1 page mentions it only as an optional way to get more value out of those therapies and nurse practitioner calls. No GLP-1 buyer has to pay it.

No membership figure is published anywhere either. Restore says prices vary by studio and by membership type and points you at a local studio page, and its three named tiers are described entirely in credits, with no dollar figure attached to any of them.

One priced membership fact does exist, and it's location-scoped: an up-charge is added to one membership's IV appointments in one state's studios. It has nothing to do with the medication.

Named clinicians, a studio count, no state list

One hundred and twenty of the four hundred and twenty sellers here name an individual prescribing clinician, and Restore is one: a chief medical officer and a chief science officer, both named with credentials. The company also states that medical services are provided by an independently owned physician practice, which is a structural disclosure rather than a marketing one.

Two hundred and eighty-six of the four hundred and twenty sellers here publish no service area, and Restore is one of them. What it does publish is a studio count, and the locations page is a search tool that renders no list of states at all.

It names its operating entity and its trading name and publishes a governing-law state, which is fuller corporate disclosure than a good deal of this comparison offers.

The GLP-1 page cites two named clinical trials with percentage figures, attributed to the trials, and prints its own caveat beside them: real-world results from these therapies often differ. That caveat is Restore's own, and it's worth repeating.